Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

C.H. Polman; A. Bertolotto; F. Deisenhammer; G. Giovannoni; H.P. Hartung; B. Hemmer; J. Killestein; H.F. McFarland; J. Oger; A.R. Pachner; J. Petkau; A.T. Reder; S.C. Reingold; H. Schellekens; P.S. Sorensen

doi:10.1016/S1474-4422(10)70103-4

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

C.H. Polman
, A. Bertolotto
, F. Deisenhammer
, G. Giovannoni
, H.P. Hartung
, B. Hemmer
, J. Killestein
, H.F. McFarland
, J. Oger
, A.R. Pachner
, J. Petkau
, A.T. Reder
, S.C. Reingold
, H. Schellekens
, P.S. Sorensen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	740-750
Journal	Lancet neurology
Volume	9
Issue number	7
DOIs	https://doi.org/10.1016/S1474-4422(10)70103-4
Publication status	Published - 2010

Access to Document

10.1016/S1474-4422(10)70103-4

Cite this

Polman, C. H., Bertolotto, A., Deisenhammer, F., Giovannoni, G., Hartung, H. P., Hemmer, B., Killestein, J., McFarland, H. F., Oger, J., Pachner, A. R., Petkau, J., Reder, A. T., Reingold, S. C., Schellekens, H., & Sorensen, P. S. (2010). Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet neurology, 9(7), 740-750. https://doi.org/10.1016/S1474-4422(10)70103-4

@article{01f993f9f4ff4155b2678af35a78e7d2,

title = "Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis",

author = "C.H. Polman and A. Bertolotto and F. Deisenhammer and G. Giovannoni and H.P. Hartung and B. Hemmer and J. Killestein and H.F. McFarland and J. Oger and A.R. Pachner and J. Petkau and A.T. Reder and S.C. Reingold and H. Schellekens and P.S. Sorensen",

year = "2010",

doi = "10.1016/S1474-4422(10)70103-4",

language = "Undefined/Unknown",

volume = "9",

pages = "740--750",

journal = "Lancet neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "7",

}

Polman, CH, Bertolotto, A, Deisenhammer, F, Giovannoni, G, Hartung, HP, Hemmer, B, Killestein, J, McFarland, HF, Oger, J, Pachner, AR, Petkau, J, Reder, AT, Reingold, SC, Schellekens, H & Sorensen, PS 2010, 'Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis', Lancet neurology, vol. 9, no. 7, pp. 740-750. https://doi.org/10.1016/S1474-4422(10)70103-4

TY - JOUR

T1 - Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

AU - Polman, C.H.

AU - Bertolotto, A.

AU - Deisenhammer, F.

AU - Giovannoni, G.

AU - Hartung, H.P.

AU - Hemmer, B.

AU - Killestein, J.

AU - McFarland, H.F.

AU - Oger, J.

AU - Pachner, A.R.

AU - Petkau, J.

AU - Reder, A.T.

AU - Reingold, S.C.

AU - Schellekens, H.

AU - Sorensen, P.S.

PY - 2010

Y1 - 2010

U2 - 10.1016/S1474-4422(10)70103-4

DO - 10.1016/S1474-4422(10)70103-4

M3 - Article

SN - 1474-4422

VL - 9

SP - 740

EP - 750

JO - Lancet neurology

JF - Lancet neurology

IS - 7

ER -